Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Protective Effects of Hydro-Alcoholic Extract of Coriandrum sativum in Rats with Experimental Iron-Overload Condition

Rahman Talaei 1 , Alireza Kheirollah 2 , Hossein Babaahmadi Rezaei 3 , Esrafil Mansouri 4 and Ghorban Mohammadzadeh 3 , *
Authors Information
1 Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Cellular and Molecular Research Center, Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Hyperlipidemia Research Center, Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Cellular and Molecular Research Center, Department of Anatomical Sciences, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: May 2018, 13 (2); e65028
  • Published Online: December 23, 2017
  • Article Type: Research Article
  • Received: August 20, 2016
  • Revised: November 7, 2016
  • Accepted: December 12, 2016
  • DOI: 10.5812/jjnpp.65028

To Cite: Talaei R, Kheirollah A, Babaahmadi Rezaei H, Mansouri E, Mohammadzadeh G. The Protective Effects of Hydro-Alcoholic Extract of Coriandrum sativum in Rats with Experimental Iron-Overload Condition, Jundishapur J Nat Pharm Prod. 2018 ; 13(2):e65028. doi: 10.5812/jjnpp.65028.

Abstract
Copyright © 2017, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7-15. doi: 10.1007/s12185-008-0120-5. [PubMed: 18594779].
  • 2. Sengsuk C, Tangvarasittichai O, Chantanaskulwong P, Pimanprom A, Wantaneeyawong S, Choowet A, et al. Association of Iron Overload with Oxidative Stress, Hepatic Damage and Dyslipidemia in Transfusion-Dependent beta-Thalassemia/HbE Patients. Indian J Clin Biochem. 2014;29(3):298-305. doi: 10.1007/s12291-013-0376-2. [PubMed: 24966477].
  • 3. Milic S, Mikolasevic I, Orlic L, Devcic E, Starcevic-Cizmarevic N, Stimac D, et al. The Role of Iron and Iron Overload in Chronic Liver Disease. Med Sci Monit. 2016;22:2144-51. [PubMed: 27332079].
  • 4. Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu Rev Nutr. 2010;30:105-22. doi: 10.1146/annurev.nutr.012809.104804. [PubMed: 20420524].
  • 5. Liu D, He H, Yin D, Que A, Tang L, Liao Z, et al. Mechanism of chronic dietary iron overload-induced liver damage in mice. Mol Med Rep. 2013;7(4):1173-9. doi: 10.3892/mmr.2013.1316. [PubMed: 23404080].
  • 6. Philippe MA, Ruddell RG, Ramm GA. Role of iron in hepatic fibrosis: one piece in the puzzle. World J Gastroenterol. 2007;13(35):4746-54. doi: 10.3748/wjg.v13.i35.4746. [PubMed: 17729396].
  • 7. Kew MC. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer. 2014;3(1):31-40. doi: 10.1159/000343856. [PubMed: 24804175].
  • 8. Alavi S, Sadeghi E, Ashenagar A. Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload. Blood Res. 2014;49(1):72-3. doi: 10.5045/br.2014.49.1.72. [PubMed: 24724073].
  • 9. Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012;10(4):411-22. doi: 10.2450/2012.0008-12. [PubMed: 22790257].
  • 10. Hatcher HC, Singh RN, Torti FM, Torti SV. Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Med Chem. 2009;1(9):1643-70. doi: 10.4155/fmc.09.121. [PubMed: 21425984].
  • 11. Cappellini MD. Overcoming the challenge of patient compliance with iron chelation therapy. Semin Hematol. 2005;42(2 Suppl 1):S19-21. doi: 10.1053/j.seminhematol.2005.01.001. [PubMed: 15846581].
  • 12. Varzi HN, Esmailzadeh S, Morovvati H, Avizeh R, Shahriari A, Givi ME. Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs. J Vet Pharmacol Ther. 2007;30(5):477-81. doi: 10.1111/j.1365-2885.2007.00901.x. [PubMed: 17803742].
  • 13. Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, et al. Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox. Eur J Haematol. 2014;92(6):521-6. doi: 10.1111/ejh.12270. [PubMed: 24460655].
  • 14. Pandey A, Bigoniya P, Raj V, Patel KK. Pharmacological screening of Coriandrum sativum Linn. for hepatoprotective activity. J Pharm Bioallied Sci. 2011;3(3):435-41. doi: 10.4103/0975-7406.84462. [PubMed: 21966166].
  • 15. Mirzaei A, Khatami R. Antioxidant and iron chelating activity of Coriander sativum and Petroselinum crispum. Bull Environ Pharmacol Life Sci. 2013;2:27-31.
  • 16. Sreelatha S, Padma PR, Umadevi M. Protective effects of Coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats. Food Chem Toxicol. 2009;47(4):702-8. doi: 10.1016/j.fct.2008.12.022. [PubMed: 19146910].
  • 17. Matasyoh JC, Maiyo ZC, Ngure RM, Chepkorir R. Chemical composition and antimicrobial activity of the essential oil of Coriandrum sativum. Food Chem. 2009;113(2):526-9. doi: 10.1016/j.foodchem.2008.07.097.
  • 18. Lal AA, Kumar T, Murthy PB, Pillai KS. Hypolipidemic effect of Coriandrum sativum L. in triton-induced hyperlipidemic rats. Indian J Exp Biol. 2004;42(9):909-12. [PubMed: 15462185].
  • 19. Naquvi KJ, Ali M, Ahamad J. Antidiabetic activity of aqueous extract of coriandrum sativum L. fruits in streptozotocin induced rats. Int J Pharm Pharm Sci. 2011;4(239-40).
  • 20. Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Coriandrum sativum L. Afr J Pharm Pharmacol. 2012;6:2340-5.
  • 21. Wong P, Kitts D. Studies on the dual antioxidant and antibacterial properties of parsley (Petroselinum crispum) and cilantro (Coriandrum sativum) extracts. Food Chem. 2006;97(3):505-15. doi: 10.1016/j.foodchem.2005.05.031.
  • 22. Tang EL, Rajarajeswaran J, Fung SY, Kanthimathi MS. Antioxidant activity of Coriandrum sativum and protection against DNA damage and cancer cell migration. BMC Complement Altern Med. 2013;13:347. doi: 10.1186/1472-6882-13-347. [PubMed: 24517259].
  • 23. Hashim M, Lincy S, Remya V, Teena M, Anila L. Effect of polyphenolic compounds from on HO-induced oxidative stress in human lymphocytes. Food Chem. 2005;92(4):653-60. doi: 10.1016/j.foodchem.2004.08.027.
  • 24. Momin AH, Acharya SS, Gajjar AV. Coriandrum sativum-review of advances in phytopharmacology. Int J Pharm Sci Res. 2012;3:1233-9.
  • 25. Al-Snafi AE. A review on chemical constituents and pharmacological activities of Coriandrum sativum. IOSR J Pharm. 2016;6(7):17-42. doi: 10.9790/3013-067031742.
  • 26. Kath RK, Gupta RK. Antioxidant activity of hydroalcoholic leaf extract of ocimum sanctum in animal models of peptic ulcer. Indian J Physiol Pharmacol. 2006;50(4):391-6. [PubMed: 17402269].
  • 27. Claiborne A. Handbook of methods for oxygen radical research. Catalase Activity. In: Greenwald RA, editor. Boca Raton, USA: CRC Press; 1986.
  • 28. Valko M, Jomova K, Rhodes CJ, Kuca K, Musilek K. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol. 2016;90(1):1-37. doi: 10.1007/s00204-015-1579-5. [PubMed: 26343967].
  • 29. Abd Elkader M, Farouk Aly H. Protective effect of melatonin against iron overload-induced toxicity in rats. Int J Pharm Pharm Sci. 2015;7:116-21.
  • 30. Zaribaf F, Entezari MH, Hassanzadeh A, Mirzaian S. Association between dietary iron, iron stores, and serum lipid profile in reproductive age women. J Educ Health Promot. 2014;3:15. doi: 10.4103/2277-9531.127586. [PubMed: 24741655].
  • 31. Badria FA, Ibrahim AS, Badria AF, Elmarakby AA. Curcumin Attenuates Iron Accumulation and Oxidative Stress in the Liver and Spleen of Chronic Iron-Overloaded Rats. PLoS One. 2015;10(7). e0134156. doi: 10.1371/journal.pone.0134156. [PubMed: 26230491].
  • 32. Sarkar R, Hazra B, Mandal N. Hepatoprotective Potential of Caesalpinia crista against Iron-Overload-Induced Liver Toxicity in Mice. Evid Based Complement Alternat Med. 2012;2012:896341. doi: 10.1155/2012/896341. [PubMed: 22919421].
  • 33. Aziza SA, Azab Mel S, El-Shall SK. Ameliorating role of rutin on oxidative stress induced by iron overload in hepatic tissue of rats. Pak J Biol Sci. 2014;17(8):964-77. doi: 10.3923/pjbs.2014.964.977. [PubMed: 26031015].
  • 34. Galleano M, Simontacchi M, Puntarulo S. Nitric oxide and iron: effect of iron overload on nitric oxide production in endotoxemia. Mol Aspects Med. 2004;25(1-2):141-54. doi: 10.1016/j.mam.2004.02.015. [PubMed: 15051323].
  • 35. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2(8653):27-30. doi: 10.1016/S0140-6736(89)90264-X. [PubMed: 2567801].
  • 36. Powell LW, Bassett ML, Halliday JW. Hemochromatosis: 1980 update. Gastroenterology. 1980;78(2):374-81. [PubMed: 6985597].
  • 37. Jaccob AA, Hussain SA. Effects of long-term use of flavonoids on the absorption and tissue distribution of orally administered doses of trace elements in rats. Pharmacol Pharm. 2012;3(4):474-80. doi: 10.4236/pp.2012.34065.
  • 38. Kumar S, Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013;2013:162750. doi: 10.1155/2013/162750. [PubMed: 24470791].
  • 39. Ebrahimzadeh MA, Pourmorad F, Bekhradnia AR. Iron chelating activity, phenol and flavonoid content of some medicinal plants from Iran. Afr J Biotechnol. 2008;7(18):3188-92.
  • 40. Najafzadeh H, Jalali MR, Morovvati H, Taravati F. Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat. J Med Toxicol. 2010;6(1):22-6. doi: 10.1007/s13181-010-0030-9. [PubMed: 20182837].
  • 41. Ebrahimzadeh MA, Nabavi SM, Nabavi SF. Correlation between the in vitro iron chelating activity and poly phenol and flavonoid contents of some medicinal plants. Pak J Biol Sci. 2009;12(12):934-8. doi: 10.3923/pjbs.2009.934.938. [PubMed: 19777789].
  • 42. Kaltwasser JP, Werner E, Schalk K, Hansen C, Gottschalk R, Seidl C. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut. 1998;43(5):699-704. doi: 10.1136/gut.43.5.699. [PubMed: 9824354].
  • 43. Lima GPP, Vianello F, Corrêa CR, Campos RS, Borguini MG. Polyphenols in fruits and vegetables and its effect on human health. Food Nutr Sci. 2014;5(11):1065-82. doi: 10.4236/fns.2014.511117.
  • 44. Aguilera Y, Martin-Cabrejas MA, González de Mejia E. Phenolic compounds in fruits and beverages consumed as part of the mediterranean diet: their role in prevention of chronic diseases. Phytochem Rev. 2015;15(3):405-23. doi: 10.1007/s11101-015-9443-z.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments